国家免疫技术咨询小组如何评估和使用证据:SYSVAC调查结果
该横断面在线调查纳入全球108名参与者,旨在了解国家免疫技术咨询小组(NITAG)在证据检索方面的用户体验,并评估SYSVAC资源与培训需求。受访者多来自50个NITAG,覆盖WHO六个区域,其中13/50(26.0%)能方便获取全文文献。制定疫苗推荐时,受访者称主要使用系统综述(83.2%)、他国推荐(79.4%)和原始研究(73.8%);35个NITAG使用SYSVAC登记库检索证据,支持全球NITAG制定至少69条推荐。
要点
- 调查覆盖50个NITAG,13/50(26.0%)能方便获取全文文献。
- 制定疫苗推荐时,83.2%受访者使用系统综述,79.4%使用他国推荐,73.8%使用原始研究。
- 35个NITAG使用SYSVAC登记库检索证据,支持制定至少69条推荐。
核心结论
- 调查收集了NITAG证据使用与培训需求信息,结果可作为改善NITAG推荐制定支持的起点。
研究设计与样本
- 横断面在线调查,使用结构化问卷,全球108名参与者,代表50个NITAG,覆盖WHO六个区域。
主要发现
- 75.9%的受访者年龄大于45岁。
- 13/50个NITAG(26.0%)能方便获取全文出版物。
- 制定疫苗推荐时,受访者称使用系统综述(83.2%)、他国推荐(79.4%)和原始研究(73.8%)。
- 35个NITAG称使用SYSVAC登记库检索证据,支持全球NITAG制定至少69条推荐。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
National immunization technical advisory groups (NITAGs) develop evidence-based vaccination recommendations. Systematic reviews (SRs) are important tools in that process, but conducting them is very resource-intensive. Given the considerable number of immunization-related SRs published and to minimize duplication of effort, a more practical approach for NITAGs is to use existing SRs. Among multiple initiatives and resources to strengthen NITAGs, the freely accessible SYSVAC registry supports NITAGs in identifying suitable SRs when developing vaccination recommendations. Additional SYSVAC courses provide step-by-step training on how to use SRs. This cross-sectional survey was conducted online and involved 108 participants globally. The aim was to explore NITAGs user experience with evidence retrieval, to assess impact and use of the SYSVAC resources and training needs. Data were collected using a structured questionnaire. Most of the respondents were > 45 years old (75.9%) and represented 50 NITAGs from all six World Health Organization (WHO) regions. In total, 13/50 NITAGs (26.0%) had ease accessing full text publications. The preferred data sources to search for evidence were peer reviewed literature via PubMed and the WHO website (Strategic Advisory Group of Experts - SAGE - on Immunization). When developing vaccination recommendations, respondents stated using SRs mostly conducted by SAGE, other institutions or NITAGs (83.2%), recommendations of other countries (79.4%) and primary studies (73.8%). Respondents from 35 NITAGs stated to use the SYSVAC registry to search for evidence, leading to ≥69 recommendations being developed by NITAGs globally with its support. Aside existing SYSVAC courses on SR use, there was great interest in training on SR use in the development of vaccination recommendations. Our survey gathered information on evidence use and training needs. Survey results serve as a starting point to improve support of NITAGs in developing recommendations.
引用
- Pilic A, Henaff L, Steffen C, et al. How do national immunization technical advisory groups assess and use evidence: Findings from the SYSVAC survey. Vaccine. 2024. PMID: 39571357. doi:10.1016/j.vaccine.2024.126538
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。